as 12-13-2024 12:34pm EST
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Founded: | 1990 | Country: | United States |
Employees: | N/A | City: | FOSTER CITY |
Market Cap: | 2.5B | IPO Year: | 1996 |
Target Price: | $7.05 | AVG Volume (30 days): | 6.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.32 | EPS Growth: | N/A |
52 Week Low/High: | $1.64 - $5.34 | Next Earning Date: | 11-07-2024 |
Revenue: | $29,480,000 | Revenue Growth: | 9199.68% |
Revenue Growth (this year): | 31400% | Revenue Growth (next year): | 306.68% |
GERN Breaking Stock News: Dive into GERN Ticker-Specific Updates for Smart Investing
MT Newswires
6 hours ago
Business Wire
7 hours ago
Zacks
a day ago
Insider Monkey
2 days ago
Business Wire
3 days ago
Business Wire
3 days ago
Business Wire
16 days ago
Insider Monkey
21 days ago
The information presented on this page, "GERN Geron Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.